A Brave New World of Retina Research
Cutting-edge translational retina research for patients in Philadelphia and around the world
Allen C. Ho, Carl D. Regillo |
We live in an age where science and technology are advancing fast – but not nearly fast enough for those afflicted by blinding eye conditions. Since its inception in 1832, Wills Eye Hospital has been a leader in patient care, medical education, and translational clinical research (1). But this is no time to rest on our past achievements when there are still so many needs left unfulfilled in our clinics and surgical suites and when translational scientific advances offer potential opportunity for great benefit. These patient needs drive our team – and the whole institution – forward.
As Director of Retina Research at Wills Eye, I lead our innovative collaborations between brilliant Wills Eye Retina specialists, dedicated Wills Retina Research teammates, and industry and global study group partners – all focused on elevating the standards of care for patients in our exam rooms and around the world. Further, our highly sought-after retina fellowship programs continually bring in the best and brightest minds in our field to train with us and challenge the status quo.
Wills Eye Retina is among the most active translational retina clinical trial units in the world. Our patients have access to the latest clinical research because our doctors conceive, design, and lead studies both alone and with partners who share in our mission to elevate standards of care.
Read the full article now
Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts